News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements
Yale Cancer Center/X
Dec 11, 2024, 00:01

Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements

Yale Cancer Center shared a post on X:

“Jessica M. Stempel and Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor plus Eltrombopag is effective in reducing transfusion requirements for patients with acquired Aplastic Anemia.”

Calcineurin Inhibitor

More posts featuring Yale Cancer Center.

acquired Aplastic Anemia anemia Calcineurin Inhibitor cancer Eltrombopag Jessica M. Stempel Nikolai Podoltsev OncoDaily Oncology patients Yale Cancer Center
Special Coverage
Blog
Mar 31, 2025, 08:34
Douglas Flora: What Would Ted Lasso Do? - Leading With Heart, Not Clipboards
Blog
Mar 31, 2025, 08:32
The human stories behind cancer research - The Hospital for Sick Children
Blog
Mar 31, 2025, 08:24
Boost your career with ESTRO 2025
Blog
Mar 31, 2025, 08:09
Emily Drake: Mapping organizations that serve solely the pediatric oncology community in Canada
Blog
Mar 31, 2025, 08:01
Prof. Keith Kerr: Advancing Lung Cancer Pathology – 2025 Heine H. Hansen Award
Blog
Mar 31, 2025, 07:56
Advances in KRAS G12C-Mutated NSCLC: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 07:41
Sendurai Mani: Reflecting on Many Chapters of Life: A Powerful TEDx Talk by John Tarantino
Blog
Mar 31, 2025, 06:10
The lung cancer patient advocacy sessions at the ELCC 2025 were standout events - Lung Cancer Europe
Insight
Mar 31, 2025, 06:04
Yan Leyfman: Expanding Antibody Therapeutics with TCR Mimicry 
Blog
Mar 31, 2025, 05:50
Jennifer Bires: Proud to speak on AI and mental health at NCCS Cancer Advocacy’s Spring 2025 Cancer Policy Roundtable
Insight
Mar 31, 2025, 05:03
Jarushka Naidoo: My ELCC 2025 Top 3 - MARIPOSA, KRYSTAL7 and Deescalation trials
Blog
Mar 31, 2025, 04:59
Michael Sapienza: Federal funding for cancer and other disease research has been cut by more than $1 billion